The current valuation score of Telomir Pharmaceuticals Inc is 6.84, ranking 146 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -4.46, which is -52.90% below the recent high of -2.10 and -456.95% above the recent low of -24.86.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.